Literature DB >> 16669126

Oculo-respiratory syndrome following influenza vaccination: review of post-marketing surveillance through four influenza seasons in Canada.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16669126

Source DB:  PubMed          Journal:  Can Commun Dis Rep        ISSN: 1188-4169


× No keyword cloud information.
  4 in total

1.  Technical guidelines for the application of seasonal influenza vaccine in China (2014-2015).

Authors:  Luzhao Feng; Peng Yang; Tao Zhang; Juan Yang; Chuanxi Fu; Ying Qin; Yi Zhang; Chunna Ma; Zhaoqiu Liu; Quanyi Wang; Genming Zhao; Hongjie Yu
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  Immunogenicity of a monovalent influenza A(H1N1)pdm09 vaccine in patients with hematological malignancies.

Authors:  Yuichiro Ide; Yutaka Imamura; Satoko Ohfuji; Wakaba Fukushima; Saburo Ide; Chiyo Tsutsumi; Masahisa Koga; Kazuhiro Maeda; Yoshio Hirota
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

3.  Elevated inflammatory mediators in adults with oculorespiratory syndrome following influenza immunization: a public health agency of Canada/Canadian Institutes of Health Research Influenza Research Network Study.

Authors:  Mona Al-Dabbagh; Keswadee Lapphra; David W Scheifele; Scott A Halperin; Joanne M Langley; Patricia Cho; Tobias R Kollmann; Yan Li; Gaston De Serres; Edgardo S Fortuno; Julie A Bettinger
Journal:  Clin Vaccine Immunol       Date:  2013-05-22

Review 4.  Unique features of a recombinant haemagglutinin influenza vaccine that influence vaccine performance.

Authors:  Arun B Arunachalam; Penny Post; Deborah Rudin
Journal:  NPJ Vaccines       Date:  2021-12-02       Impact factor: 7.344

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.